Crossmark

Dynamic three dimensional environment for efficient and large scale generation of smooth muscle cells from hiPSCs

Crossref DOI link: https://doi.org/10.1186/s13287-024-04053-z

Published Online: 2024-12-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Green, Akazha

Wei, Yuhua

Warram, Jason M.

Hartman, Yolanda E.

Geng, Xiaoxiao

Nguyen, Thanh

Ye, Lei

Zhang, Jianyi
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute ((R01HL11412O)

National Heart, Lung, and Blood Institute (R01HL131017)

National Heart, Lung, and Blood Institute (U01HL134764)

National Heart, Lung, and Blood Institute (P01 HL160476))

National Institute of Biomedical Imaging and Bioengineering (T323B023872)
License Information

Text and Data Mining valid from 2024-12-03

Version of Record valid from 2024-12-03
More Information

Article History

Received: 2 June 2024

Accepted: 7 November 2024

First Online: 3 December 2024

Declarations

:

: The animal study is a part of IACUA protocol (20216) entitled “Myocardial Repair Using Human iPSC Derived Cardiac Muscle Patch” which was approved by the IACUC of the University of Alabama, Birmingham, on 2nd December 2022, and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH publication No 85–23). This study did not involve any human participants or identifiable personal data. The research was conducted solely using hiPSCs reprogrammed from fibroblasts isolated from de-identified explanted hearts, which had written informed consent from the patient(s) or their next of kin(s).

: All authors agreed to publication.

: There is not any potential conflict of interest, including financial and non-financial.

Document is current

Any future updates will be listed below